Published in Am J Pathol on June 01, 1985
Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer (1990) 0.96
Analyses of protein extracts of human breast cancers: changes in glycoprotein content linked to the malignant phenotype. Br J Cancer (1987) 0.85
Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma. Am J Pathol (1988) 0.75
Detection of colorectal dysplasia using fluorescently labelled lectins. Sci Rep (2016) 0.75
The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem (1978) 6.92
Tumor heterogeneity. Cancer Res (1984) 6.17
Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta (1976) 2.99
Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonic carcinoma (transitional mucosa). J Clin Pathol (1979) 2.51
Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17
Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst (1976) 2.09
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (1981) 1.88
Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett (1980) 1.68
Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behavior. Biochim Biophys Acta (1978) 1.63
Peanut agglutinin, a new mitogen that binds to galactosyl sites exposed after neuraminidase treatment. J Immunol (1975) 1.58
An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer (1976) 1.52
Binding of peanut lectin to breast epithelium, human carcinomas, and a cultured rat mammary stem cell: use of the lectin as a marker of mammary differentiation. J Natl Cancer Inst (1979) 1.37
Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest (1981) 1.34
Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst (1982) 1.32
Peanut lectin-binding sites in large bowel carcinoma. Lab Invest (1982) 1.20
Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. Cancer Res (1984) 1.19
Cancer metastasis. Sci Am (1979) 1.14
Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials. Exp Cell Res (1983) 1.14
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Lectins. Sci Am (1977) 1.10
Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res (1981) 1.10
Alterations in membrane sugars during epidermal differentiation: visualization with lectins and role of glycosidases. J Histochem Cytochem (1983) 1.06
Carbohydrate changes in glycoproteins of a poorly metastasizing wheat germ agglutinin-resistant melanoma clone. Cancer Res (1980) 1.04
Peanut agglutinin: a new marker for tissue histiocytes. Am J Clin Pathol (1982) 1.03
Glycosyltransferase and sialic acid levels of normal and transformed cells. Biochemistry (1973) 1.03
Binding of peanut lectin to thymic cortex and germinal centres of lymphoid tissue. Immunology (1981) 1.00
The chromosomes of fifty primary Rous rat sarcomas. Hereditas (1971) 0.99
Carcinoma-associated cytostructural antigenic alterations: detection by lectin binding. Cancer (1981) 0.98
Lectin histochemistry of malignant tumors. II. Concanavalin A: a new histochemical marker for macrophage-histiocytes in follicular lymphoma. Cancer (1983) 0.95
Tissue binding of lectins in disorders of the breast. Cancer (1983) 0.94
Peanut lectin-binding sites in polyps of the colon and rectum. Adenomas, hyperplastic polyps, and adenomas with in situ carcinoma. Lab Invest (1983) 0.93
Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B16 melanoma sublines of various metastatic properties. Cancer Res (1984) 0.93
Differences in cell surface antigens of tumor metastases and those of the local tumor. J Natl Cancer Inst (1979) 0.90
Histochemical studies on lectin binding in reactive lymphoid tissues. J Histochem Cytochem (1983) 0.89
Histochemically demonstrable changes in cell surface carbohydrates of human germ cell tumors. Lab Invest (1984) 0.89
Lectin binding to normal and malignant breast tissue. Diagn Histopathol (1984) 0.87
Prognostic value of concanavalin A reactivity of primary human breast cancer cells. Cancer Res (1981) 0.86
The binding of peroxidase-labelled lectins to human breast epithelium. I--Normal, hyperplastic and lactating breast. J Pathol (1984) 0.84
Lectin-binding affinities of human epidermal tumors and related conditions. Am J Clin Pathol (1981) 0.84
Peanut lectin binding sites in transitional cell carcinoma of the urinary bladder. Cancer (1984) 0.83
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate. Lab Invest (1984) 0.83
Lectin binding properties of glycoproteins in cells of normal gastric mucosa and gastric cancers: a comparative histochemical and biochemical study. Cancer Detect Prev (1983) 0.82
Carcinoma of the bladder: predictors. Cancer (1980) 0.82
Membrane-associated alterations detected in poorly tumorigenic lectin-resistant variant sublines of a highly malignant and metastatic murine tumor. J Natl Cancer Inst (1981) 0.81
Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status. Virchows Arch A Pathol Anat Histopathol (1984) 0.81
Lectin-binding affinities of human breast tumors. Cancer (1983) 0.80
Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma. Br J Cancer (1982) 0.79
Effects of histological processing on lectin binding patterns in oral mucosa and skin. Histochem J (1983) 0.78
Lectin binding patterns in diffuse large cell lymphoma. Cancer (1983) 0.78
Peanut lectin agglutinin and alpha-lactalbumin. Binding and immunohistochemical localization in breast tissues. Arch Pathol Lab Med (1984) 0.77
Peanut agglutinin (PNA) binding sites: a useful marker for hormonal dependence in experimental breast cancer. Cancer Detect Prev (1983) 0.76
Lectin-resistant variants of mouse melanoma cells. II. In vitro characteristics. Int J Cancer (1983) 0.76
Altered binding of Ulex europaeus I lectin to psoriatic epidermis. Br J Dermatol (1983) 0.76
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol (1983) 1.80
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer (1999) 1.55
Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes. Clin Exp Immunol (1968) 1.47
Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases. Clin Exp Immunol (1968) 1.45
The correlation of Ki67 growth factor and ERICA in breast cancer. Mod Pathol (1992) 1.44
Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients. Ann Surg Oncol (2000) 1.44
Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol (1986) 1.28
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med (1971) 1.27
Synthesis, assembly and secretion of gamma-globulin by mouse myeloma cells. V. Balanced and unbalanced synthesis of heavy and light chains by IgG-producing tumors and cell lines. J Immunol (1973) 1.26
Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol (1978) 1.26
Immunoglobulin production and secretion by variant clones of the MOPC 315 mouse myeloma cell line. J Immunol (1980) 1.23
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Cancer (1983) 1.23
Synthesis, assembly and secretion of mouse immunoglobulin. Transplant Rev (1973) 1.19
Salivary gland components involved in the formation of squamous metaplasia. Am J Pathol (1985) 1.18
Malignant myoepithelioma of the breast. An immunohistochemical study by light and electron microscopy. Cancer (1986) 1.18
Changes in Ia expression in mouse kidney during acute graft-vs-host disease. J Immunol (1984) 1.17
Outer medullary circulatory defect in ischemic acute renal failure. Am J Pathol (1984) 1.16
Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics (1984) 1.15
Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers. Clin Exp Immunol (1968) 1.15
Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability. J Immunol (1975) 1.11
Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol (1983) 1.11
Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res (1993) 1.11
S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors. Am J Pathol (1991) 1.09
Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Ann Surg Oncol (2000) 1.06
Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the alpha 5 chain of collagen type IV. Proc Natl Acad Sci U S A (1994) 1.06
Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis. Clin Exp Immunol (1969) 1.06
Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol (1997) 1.05
Advanced scleroderma bowel: complications and management. J Rheumatol (1988) 1.04
Polyclonal gammopathy and lymphoproliferation after transfer factor in severe combined immunodeficiency disease. N Engl J Med (1973) 1.03
Immunohistochemistry of intravascular papillary endothelial hyperplasia. J Cutan Pathol (1990) 1.02
The identification of mouse myeloma cells which have undergone mutations in immunoglobulin production. Soc Gen Physiol Ser (1974) 1.01
Myoepithelial cells in salivary gland tumors. An immunohistochemical study. Arch Pathol Lab Med (1985) 1.00
Casein-induced murine amyloidosis: amyloidogenesis in vitro by monolayer spleen explants of casein-injected mice. Lab Invest (1978) 1.00
Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line. Cancer Res (1986) 0.99
Salivary gland monomorphic adenoma. Ultrastructural, immunoperoxidase, and histogenetic aspects. Am J Pathol (1984) 0.98
Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int (1986) 0.96
Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Am J Pathol (1982) 0.96
Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat (2001) 0.94
Samoyed hereditary glomerulopathy (SHG). Evolution of splitting of glomerular capillary basement membranes. Am J Pathol (1986) 0.94
Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease. Clin Nephrol (1983) 0.93
Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion. Eur J Immunol (1979) 0.93
Proliferative activity and p53 expression in adenoid cystic carcinoma of the breast. Mod Pathol (1996) 0.93
Nodular regenerative hyperplasia of the liver associated with progressive systemic sclerosis: a case report with ultrastructural observation. J Rheumatol (1983) 0.93
Categorization of pediatric neoplasms by immunostaining with antiprekeratin and antivimentin antisera. Cancer (1983) 0.92
The effects of nicotine on Parkinson's disease. Brain Cogn (2000) 0.92
Cloning and expression of the human S100 beta gene. J Biol Chem (1990) 0.92
The significance of focal segmental glomerulosclerosis in oligomeganephronia. Int J Pediatr Nephrol (1984) 0.91
Xanthogranulomatous pyelonephritis in children. Etiology, pathogenesis, clinical and radiologic features, and management. Clin Pediatr (Phila) (1994) 0.91
Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice. J Clin Invest (1998) 0.91
Characterization of binding of four monoclonal antibodies to the human ovarian adenocarcinoma cell line HEY. Biochem Cell Biol (1987) 0.91
S100 protein expression in human melanoma cells: comparison of levels of expression among different cell lines and individual cells in different phases of the cell cycle. Exp Cell Res (1990) 0.91
bcl-2 protein expression in melanocytic neoplasms of the skin. Mod Pathol (1995) 0.91
Animal model of human disease: hereditary nephritis in Samoyed dogs. Am J Pathol (1984) 0.91
Epithelial proliferation in thymic hyperplasia. An immunohistochemical study and correlation with the developing fetal thymus. Arch Pathol Lab Med (1989) 0.90
Idiopathic membranous glomerulopathy in Canadian children: a clinicopathologic study. J Pediatr (1982) 0.90
Erythroblastosis fetalis and hyperbilirubinemia. A five-year follow-up with neurological, psychological, and audiological evaluation. Pediatrics (1967) 0.90
Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies. Tumour Biol (1988) 0.89
A monoclonal antiidiotypic antibody to MOPC 315 IgA inhibits the growth of MOPC 315 myeloma cells in vitro. J Immunol (1981) 0.89
Histochemical and immunohistochemical characterization of surgically resected and heterotransplanted Wilms' tumor. Cancer Res (1985) 0.89
Mode of inheritance of Samoyed hereditary glomerulopathy: an animal model for hereditary nephritis in humans. J Lab Clin Med (1986) 0.89
Is there a decline in picture naming with advancing age? J Speech Hear Res (1994) 0.89
Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci U S A (1986) 0.88
Pediatric renal transplants: a Canadian perspective. Kidney Int Suppl (1986) 0.88
Abnormalities in the NC1 domain of collagen type IV in GBM in canine hereditary nephritis. Kidney Int (1989) 0.88
Localized fibrous tumour of serosal surfaces. Immunohistochemical and ultrastructural evidence for a type of mesothelioma. Virchows Arch A Pathol Anat Histopathol (1986) 0.87
Histamine-releasing activity of rheumatoid and nonrheumatoid serum and synovial fluid. Ann N Y Acad Sci (1969) 0.87
Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect. J Pediatr (1990) 0.86
Ultrastructural and immunohistochemical characteristics of mucoepidermoid carcinoma of the breast. Hum Pathol (1985) 0.86
A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. APMIS (1988) 0.85
Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone. Surg Oncol (1997) 0.85
An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays. J Steroid Biochem Mol Biol (1996) 0.85
Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases. Mod Pathol (1990) 0.85
Palisaded encapsulated neuroma: an immunohistochemical study. Mod Pathol (1989) 0.84
S100beta inhibits alpha1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J Biol Chem (1997) 0.84
Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside. Mod Pathol (1999) 0.84
Relationship of histology of Wilms' tumor to growth characteristics of nude mouse heterotransplants. Cancer Res (1985) 0.84
Primary malignant lymphoma of the spleen in systemic lupus erythematosus. J Rheumatol (1989) 0.84
Immunoreactivity of S100 beta in heart, skeletal muscle, and kidney in chronic lung disease: possible induction by cAMP. Mod Pathol (1991) 0.83
Galactose-conjugated antibodies in cancer therapy: properties and principles of action. Cancer Res (1991) 0.83
Variations in the synthesis and assembly of immunoglobulins by mouse myeloma cells: a genetic and biochemical analysis. J Cell Physiol (1970) 0.83
Prognostic significance of urinary findings and renal biopsies in children with Henoch-Schönlein nephritis. Clin Pediatr (Phila) (1986) 0.83
The use of cytoskeletal characteristics of tumor cells for the diagnosis of colon and breast adenocarcinomas. Am J Clin Pathol (1986) 0.83
The structural conservation of S100 protein during evolution: analysis by reactivity with a monoclonal antibody. J Neurochem (1983) 0.82
Cadaveric renal transplants in children under 6 years of age. Kidney Int Suppl (1983) 0.82
Studies of reversed anaphylaxis in the perfused guinea-pig lung. Immunology (1972) 0.82
Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis. J Immunol (1975) 0.81